Genetic Test Evaluation

understanding how genetic tests impact patient management

Colvera (Clinical Genomics Pathology Inc.)

November 14, 2018

This report evaluates the analytical validity, clinical validity, and clinical utility of Colvera, a circulating tumor DNA (ctDNA) liquid biopsy test, to accurately identify residual disease or recurrence in patients with previously treated stage I through IV primary colorectal cancer (CRC).